2019 annual financial data
Seres Therapeutics 2019 Net margin
Direct answer
Net margin was -203.68%.
Operating income was -71.88M USD and net income was -70.28M USD.
Operating cash flow was -76.52M USD.
Get free Seres Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 34.51M USD
- Operating income
- -71.88M USD
- Net income
- -70.28M USD
- Operating cash flow
- -76.52M USD